Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain
Harry F. Dovey(Sunesis (United States)), B. Ni(Eli Lilly (United States)), Leonard N. Boggs(Eli Lilly (United States)), P. D. S. int Andrieu, Shao-Hua Yang, James C. Clemens(Eli Lilly (United States)), Zhengchang Liao, Donna K. Dieckman-McGinty(Eli Lilly (United States)), K. L. Sacchi, Lanlan Fang(Anhui Medical University), J. J. Droste(Eli Lilly (United States)), Dan L. Czilli(Eli Lilly (United States)), S. L. Kennedy, Paul A. Hyslop(Eli Lilly (United States)), Jay S. Tung(Sunesis (United States)), Thomas E. Mabry(Eli Lilly (United States)), T. C. Britton(Eli Lilly (United States)), L. Z. Chen, Eugene D. Thorsett, Bruce D. Gitter(Eli Lilly (United States)), Varghese John(University of California, Los Angeles), Mark H. Bender(Eli Lilly (United States)), F. DeWolfe Miller(Eli Lilly (United States)), Dora Kholodenko, Linda Mutter, M. Lee, B. Folmer, Kevin P. Quinn, J. Nietz, Jeroen Knops(Sunesis (United States)), Peter Seubert(Sunesis (United States)), Ruth Motter, Erich Goldbach, Ivan Lieberburg(Sunesis (United States)), Chen Yin, Kang Hu, Stephen B. Freedman, Kelly Johnson‐Wood, George M. Shopp, Kimberly S. Fuson(Eli Lilly (United States)), Lee H. Latimer, Elzbieta J. Holsztynska, Edward M. Johnstone(Eli Lilly (United States)), Jing Wu(XinHua Hospital), Patrick C. May(Eli Lilly (United States)), L. Altstiel(Eli Lilly (United States)), Dale B. Schenk(Heidelberg University), J. P. Anderson, Sharon Little(Eli Lilly (United States)), W‐Y. Li(Eli Lilly (United States))
Cited by 879
Related Papers
Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
|Nature Genetics|1997|835
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
|Neurology|2009|739